CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis

Cancer Letters

Volumn 361, Issue 1, 2015, Pages 22-32

  Xiao, You Chuan ^a,b,c   Yang, Zhi Bin ^a   Cheng, Xian Shuo ^a,b   Fang, Xing Bao ^b,c   Shen, Tao ^a   Xia, Cui Feng ^a   Liu, Ping ^a   Qian, Hai Hua ^b   Sun, Bin ^b   Yin, Zheng Feng ^b   Li, Yun Feng ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c First People's Hospital of Qujing   (China)

Author keywords

Anoikis; Colorectal cancer; CXCL 8; Prognosis; TOPK

Indexed keywords

INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; TLAK CELL ORIGINATED PROTEIN KINASE; UNCLASSIFIED DRUG; IL8 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PDZ-BINDING KINASE; TUMOR MARKER;

ADULT; AGED; ANOIKIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; ADOLESCENT; CANCER GRADING; COLLOID CARCINOMA; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; LIVER TUMOR; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SECONDARY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; TUMOR INVASION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANOIKIS; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-8; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84925147568     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.021     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., et al. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
2. Woodhouse E.C., Chuaqui R.F., Liotta L.A. General mechanisms of metastasis. Cancer 1997, 80:1529-1537.
3. Chiarugi P., Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem. Pharmacol 2008, 76:1352-1364.
4. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
5. Arenberg D.A., Kunkel S.L., Polverini P.J., Glass M., Burdick M.D., et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest 1996, 97:2792-2802.
6. Inoue K., Slaton J.W., Eve B.Y., Kim S.J., Perrotte P., et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin. Cancer Res 2000, 6:2104-2119.
7. Fox S.H., Whalen G.F., Sanders M.M., Burleson J.A., Jennings K., et al. Angiogenesis in normal tissue adjacent to colon cancer. J. Surg. Oncol 1998, 69:230-234.
8. Fernando R.I., Castillo M.D., Litzinger M., Hamilton D.H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res 2011, 71:5296-5306.
9. Hwang W.L., Yang M.H., Tsai M.L., Lan H.Y., Su S.H., et al. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011, 141:279-291. 291 e271-275.
10. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128:2038-2049.
11. Reginato M.J., Mills K.R., Paulus J.K., Lynch D.K., Sgroi D.C., et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol 2003, 5:733-740.
12. Zeng Q., Chen S., You Z., Yang F., Carey T.E., et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. J. Biol. Chem 2002, 277:25203-25208.
13. Watanabe S., Kishimoto T., Yokosuka O. Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway. Pancreas 2011, 40:608-614.
14. Gazzaniga P., Raimondi C., Gradilone A., Naso G., Cortesi E., et al. Circulating tumor cells: highlight on practical implications. Mol. Diagn. Ther 2012, 16:7-11.
15. Kim D.J., Li Y., Reddy K., Lee M.H., Kim M.O., et al. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res 2012, 72:3060-3068.
16. Zhu F., Zykova T.A., Kang B.S., Wang Z., Ebeling M.C., et al. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology 2007, 133:219-231.
17. Hu F., Gartenhaus R.B., Eichberg D., Liu Z., Fang H.B., et al. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene 2010, 29:5464-5474.
18. Zhang Z., Cao L., Li J., Liang X., Liu Y., et al. Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells. Cancer Lett 2008, 267:106-115.
19. Cheng X.S., Li Y.F., Tan J., Sun B., Xiao Y.C., et al. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cancer Lett 2014, 348:77-87.
20. Zhang Y., Davis C., Ryan J., Janney C., Pena M.M. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. Clin. Exp. Metastasis 2013, 30:903-918.
21. Berezovskaya O., Schimmer A.D., Glinskii A.B., Pinilla C., Hoffman R.M., et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 2005, 65:2378-2386.
22. Taddei M.L., Giannoni E., Fiaschi T., Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J. Pathol 2012, 226:380-393.
23. Chen H.J., Edwards R., Tucci S., Bu P., Milsom J., et al. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J. Clin. Invest 2012, 122:3184-3196.
24. Baier P.K., Eggstein S., Wolff-Vorbeck G., Baumgartner U., Hopt U.T. Chemokines in human colorectal carcinoma. Anticancer Res 2005, 25:3581-3584.
25. Singh R., Lillard J.W., Singh S. Chemokines: key players in cancer progression and metastasis. Front. Biosci 2011, 3:1569-1582.
26. Li A., Varney M.L., Singh R.K. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin. Cancer Res 2001, 7:3298-3304.
27. Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007, 12:913-922.
28. Wang Z., Cai F., Chen X., Luo M., Hu L., et al. The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis. PLoS ONE 2013, 8:e75044.
29. Zobeiri F., Salami S., Sadrkhanlou R., Peirouvi T. Role of mitochondria in ciprofloxacin-induced apoptosis in murine sperm cells. Reprod. Sci 2013, 20:1090-1095.
30. Dutta C., Day T., Kopp N., van Bodegom D., Davids M.S., et al. BCL2 suppresses PARP1 function and nonapoptotic cell death. Cancer Res 2012, 72:4193-4203.
31. Diaz-Montero C.M., Wygant J.N., McIntyre B.W. PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. Eur. J. Cancer 2006, 42:1491-1500.
32. Liau S.S., Jazag A., Ito K., Whang E.E. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells. Br. J. Cancer 2007, 96:993-1000.
33. Toricelli M., Melo F.H., Peres G.B., Silva D.C., Jasiulionis M.G. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol. Cancer 2013, 12:22.
34. Galante J.M., Mortenson M.M., Bowles T.L., Virudachalam S., Bold R.J. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J. Surg. Res 2009, 152:18-25.
35. Goncharenko-Khaider N., Matte I., Lane D., Rancourt C., Piche A. Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis. Mol. Cancer 2012, 11:84.
36. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res 2008, 14:6735-6741.